The innovative development of cancer therapies has led to an unprecedented improvement
in survival outcomes and a wide array of treatment-related toxicities, including those that are …

Cardiovascular disease and cancer are the 2 main causes of death in the United States.
They intersect on multiple levels, sharing common causal mechanisms and epidemiological …

There is an increasing awareness and clinical interest in cardiac safety during cancer
therapy as well as in optimally addressing cardiac issues in cancer survivors. Although there …

From 1935 to 2013, cardiovascular diseases and cancer have been the 2 leading causes of
death such that, in 2010, heart disease and cancer accounted for 46% of all deaths in the …

Cardio-oncology is a multidisciplinary field focusing on the management and prevention of
cardiovascular complications in cancer patients and survivors. While the initial focus of this …

Cardio‐oncology is a rapidly growing field of cardiovascular (CV) medicine that has resulted
from the continuously increasing clinical demand for specialized CV evaluation, prevention …

Over the past decades, there have been great advancements in the survival outcome of
patients with cancer. As a consequence, treatment regimens are being extended to patient …

Improved cancer survivorship has resulted in a growing number of Canadians affected by
cancer and cardiovascular disease. As a consequence, cardio-oncology programs are …

Background The diagnosis and management of cardiovascular complications have become
a clinical concern for oncologists, cardiologists, surgeons, interventional radiologists …

Simple Summary Modern cancer therapies have achieved a remarkable improvement in
overall survival and patients' quality of life. However, cardiovascular toxicities are still a …